3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Diseases
1
Pain
1
Leiomyoma
1
Inflammation
1
Hyperuricemia
1
Gout
1
Dysmenorrhea
1
Cardiovascular Diseases
1
Arthritis
1
Interventions
Fentanyl
9
Acetaminophen
5
Zoledronic Acid
4
Oxycodone
4
Ketamine
4
Bupivacaine
4
Sufentanil
3
Hydromorphone
3
Diclofenac
3
Ropivacaine
2
Pregabalin
2
Morphine
2
Ketorolac
2
Ibuprofen
2
Ibandronic Acid
2
Esketamine
2
Epinephrine
2
naloxegol
1
chloroprocaine
1
acetaminophen, aspirin, caffeine drug combination
1
Varenicline
1
Uterine Artery Embolization
1
Ultracet
1
Therapeutics
1
Propofol
1
Pamidronate
1
Oxygen
1
Nitrous Oxide
1
Naproxen
1
Midazolam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pain
×
Naproxen
×
Clear all
NCT04145518
2025-12-12
MCUP
Endeavor Health
Phase 4
Completed
183 enrolled